(Q41090385)

26 September 2017

Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells (English)

1 reference

26 September 2017

Jayaram HN

1

1 reference

26 September 2017

Gharehbaghi K

2

1 reference

26 September 2017

Jayaram NH

3

1 reference

26 September 2017

Rieser J

4

1 reference

26 September 2017

Krohn K

5

1 reference

26 September 2017

Paull KD

6

1 reference

26 September 2017

1 August 1992

1 reference

Biochemical and Biophysical Research Communications

26 September 2017

1 reference

26 September 2017

186

1 reference

26 September 2017

1600-1606

1 reference

26 September 2017

3

1 reference

Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogs

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

A straightforward radiometric technique for measuring IMP dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

Biochemical mechanisms of resistance to tiazofurin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2805%2981591-8

10.1016/S0006-291X(05)81591-8

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference